
LINK . SPRINGER . COM {
}
Title:
Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON | Journal of Gastroenterology
Description:
GIDEON was a prospective, global, non-interventional study evaluating the safety of sorafenib in patients with unresectable hepatocellular carcinoma in real-world practice. The aim of this subgroup analysis was to assess the safety and efficacy of sorafenib as used by Japanese patients. In Japan, 508 patients were valid for safety analysis. Efficacy and safety were evaluated by the Child-Pugh score. The number of patients with Child-Pugh A and B was 432 (85.0 %) and 58 (11.4 %), respectively. The median overall survival time and time to progression in patients with Child-Pugh A and Child-Pugh B were 17.4 and 4.9 months, 3.7 and 2.3 months, respectively. The most common drug-related adverse events (AEs) included hand-foot skin reaction (47.8 %), diarrhea (35.8 %) and hypertension (24.2 %). The incidences of all or drug-related AEs were similar between patients with Child-Pugh A and B. However, all or drug-related serious AEs, AEs resulting in permanent discontinuation of sorafenib and deaths were observed more frequently in patients with Child-Pugh B compared with Child-Pugh A. Duration of treatment tended to be shorter as the Child-Pugh score worsened. Sorafenib was well tolerated by Japanese HCC patients in clinical settings. Patients with Child-Pugh B had shorter duration of treatment and higher incidence of SAEs. It is important to carefully evaluate patients’ conditions and assess the benefit and risk before making a decision to treat patients with sorafenib.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Education
- Insurance
- Science
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 7,643,328 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We can't see how the site brings in money.
Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com could be secretly minting cash, but we can't detect the process.
Keywords {🔍}
patients, sorafenib, childpugh, article, hepatocellular, carcinoma, japan, treatment, pubmed, aes, google, scholar, study, bclc, liver, stage, japanese, drugrelated, safety, incidence, analysis, gideon, cancer, therapy, hcc, ttp, tace, higher, score, median, cas, table, data, kudo, surveillance, received, efficacy, regions, shown, months, rate, pharma, pharmaceutical, number, time, similar, practice, global, start, sessions,
Topics {✒️}
hand-foot skin reaction article download pdf raf/mek/erk pathway post-marketing surveillance manager gideon original article—liver hepatocellular carcinoma–current status intermediate-stage hepatocellular carcinoma treatment-emergent death occurring worse child-pugh score transarterial chemoembolization failure/refractoriness drug-related aes reported child-pugh score worsened open-label study real-world practice data advanced hepatocellular carcinoma oral multikinase inhibitor baseline child-pugh status privacy choices/manage cookies satoshi yamashita related subjects full access drug-related aes author information authors daily medical practice complex medical situation cancer-related death real-world practice masatoshi kudo hepatic-related events transcatheter arterial chemoembolization received research grants drug-related saes article kudo abnormal laboratory tests nat rev cancer metastatic colorectal cancer molecular mechanisms involved conditions privacy policy phase iii randomised unresectable hepatocellular carcinoma previously published [16] outpatients diagnosed histologically decreased platelet count advisory committee immediately aliment pharmacol ther ethics declarations conflict kyowa hakko kirin bristol-myers squibb response evaluation criteria decrease patient quality
Schema {🗺️}
WebPage:
mainEntity:
headline:Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON
description:GIDEON was a prospective, global, non-interventional study evaluating the safety of sorafenib in patients with unresectable hepatocellular carcinoma in real-world practice. The aim of this subgroup analysis was to assess the safety and efficacy of sorafenib as used by Japanese patients. In Japan, 508 patients were valid for safety analysis. Efficacy and safety were evaluated by the Child-Pugh score. The number of patients with Child-Pugh A and B was 432 (85.0 %) and 58 (11.4 %), respectively. The median overall survival time and time to progression in patients with Child-Pugh A and Child-Pugh B were 17.4 and 4.9 months, 3.7 and 2.3 months, respectively. The most common drug-related adverse events (AEs) included hand-foot skin reaction (47.8 %), diarrhea (35.8 %) and hypertension (24.2 %). The incidences of all or drug-related AEs were similar between patients with Child-Pugh A and B. However, all or drug-related serious AEs, AEs resulting in permanent discontinuation of sorafenib and deaths were observed more frequently in patients with Child-Pugh B compared with Child-Pugh A. Duration of treatment tended to be shorter as the Child-Pugh score worsened. Sorafenib was well tolerated by Japanese HCC patients in clinical settings. Patients with Child-Pugh B had shorter duration of treatment and higher incidence of SAEs. It is important to carefully evaluate patients’ conditions and assess the benefit and risk before making a decision to treat patients with sorafenib.
datePublished:2016-04-22T00:00:00Z
dateModified:2016-04-22T00:00:00Z
pageStart:1150
pageEnd:1160
license:http://creativecommons.org/licenses/by/4.0/
sameAs:https://doi.org/10.1007/s00535-016-1204-2
keywords:
Hepatocellular carcinoma
Sorafenib
Japanese
GIDEON
Gastroenterology
Hepatology
Abdominal Surgery
Colorectal Surgery
Surgical Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00535-016-1204-2/MediaObjects/535_2016_1204_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00535-016-1204-2/MediaObjects/535_2016_1204_Fig2_HTML.gif
isPartOf:
name:Journal of Gastroenterology
issn:
1435-5922
0944-1174
volumeNumber:51
type:
Periodical
PublicationVolume
publisher:
name:Springer Japan
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Masatoshi Kudo
affiliation:
name:Kinki University School of Medicine
address:
name:Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Masafumi Ikeda
affiliation:
name:National Cancer Center Hospital East
address:
name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
name:Tadatoshi Takayama
affiliation:
name:Nihon University School of Medicine
address:
name:Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Kazushi Numata
affiliation:
name:Yokohama City University Medical Center
address:
name:Gastroenterological Center, Yokohama City University Medical Center, Kanagawa, Japan
type:PostalAddress
type:Organization
type:Person
name:Namiki Izumi
affiliation:
name:Musashino Red Cross Hospital
address:
name:Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Junji Furuse
affiliation:
name:Kyorin University
address:
name:Department of Internal Medicine, Medical Oncology, School of Medicine, Kyorin University, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Takuji Okusaka
affiliation:
name:National Cancer Center Hospital
address:
name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Masumi Kadoya
affiliation:
name:Shinshu University School of Medicine
address:
name:Department of Radiology, Shinshu University School of Medicine, Nagano, Japan
type:PostalAddress
type:Organization
type:Person
name:Satoshi Yamashita
affiliation:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd.
address:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
type:PostalAddress
type:Organization
type:Person
name:Yuichiro Ito
affiliation:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd.
address:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
type:PostalAddress
type:Organization
type:Person
name:Norihiro Kokudo
affiliation:
name:Graduate School of Medicine, University of Tokyo
address:
name:Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON
description:GIDEON was a prospective, global, non-interventional study evaluating the safety of sorafenib in patients with unresectable hepatocellular carcinoma in real-world practice. The aim of this subgroup analysis was to assess the safety and efficacy of sorafenib as used by Japanese patients. In Japan, 508 patients were valid for safety analysis. Efficacy and safety were evaluated by the Child-Pugh score. The number of patients with Child-Pugh A and B was 432 (85.0 %) and 58 (11.4 %), respectively. The median overall survival time and time to progression in patients with Child-Pugh A and Child-Pugh B were 17.4 and 4.9 months, 3.7 and 2.3 months, respectively. The most common drug-related adverse events (AEs) included hand-foot skin reaction (47.8 %), diarrhea (35.8 %) and hypertension (24.2 %). The incidences of all or drug-related AEs were similar between patients with Child-Pugh A and B. However, all or drug-related serious AEs, AEs resulting in permanent discontinuation of sorafenib and deaths were observed more frequently in patients with Child-Pugh B compared with Child-Pugh A. Duration of treatment tended to be shorter as the Child-Pugh score worsened. Sorafenib was well tolerated by Japanese HCC patients in clinical settings. Patients with Child-Pugh B had shorter duration of treatment and higher incidence of SAEs. It is important to carefully evaluate patients’ conditions and assess the benefit and risk before making a decision to treat patients with sorafenib.
datePublished:2016-04-22T00:00:00Z
dateModified:2016-04-22T00:00:00Z
pageStart:1150
pageEnd:1160
license:http://creativecommons.org/licenses/by/4.0/
sameAs:https://doi.org/10.1007/s00535-016-1204-2
keywords:
Hepatocellular carcinoma
Sorafenib
Japanese
GIDEON
Gastroenterology
Hepatology
Abdominal Surgery
Colorectal Surgery
Surgical Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00535-016-1204-2/MediaObjects/535_2016_1204_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00535-016-1204-2/MediaObjects/535_2016_1204_Fig2_HTML.gif
isPartOf:
name:Journal of Gastroenterology
issn:
1435-5922
0944-1174
volumeNumber:51
type:
Periodical
PublicationVolume
publisher:
name:Springer Japan
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Masatoshi Kudo
affiliation:
name:Kinki University School of Medicine
address:
name:Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Masafumi Ikeda
affiliation:
name:National Cancer Center Hospital East
address:
name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
name:Tadatoshi Takayama
affiliation:
name:Nihon University School of Medicine
address:
name:Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Kazushi Numata
affiliation:
name:Yokohama City University Medical Center
address:
name:Gastroenterological Center, Yokohama City University Medical Center, Kanagawa, Japan
type:PostalAddress
type:Organization
type:Person
name:Namiki Izumi
affiliation:
name:Musashino Red Cross Hospital
address:
name:Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Junji Furuse
affiliation:
name:Kyorin University
address:
name:Department of Internal Medicine, Medical Oncology, School of Medicine, Kyorin University, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Takuji Okusaka
affiliation:
name:National Cancer Center Hospital
address:
name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Masumi Kadoya
affiliation:
name:Shinshu University School of Medicine
address:
name:Department of Radiology, Shinshu University School of Medicine, Nagano, Japan
type:PostalAddress
type:Organization
type:Person
name:Satoshi Yamashita
affiliation:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd.
address:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
type:PostalAddress
type:Organization
type:Person
name:Yuichiro Ito
affiliation:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd.
address:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
type:PostalAddress
type:Organization
type:Person
name:Norihiro Kokudo
affiliation:
name:Graduate School of Medicine, University of Tokyo
address:
name:Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Journal of Gastroenterology
issn:
1435-5922
0944-1174
volumeNumber:51
Organization:
name:Springer Japan
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Kinki University School of Medicine
address:
name:Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan
type:PostalAddress
name:National Cancer Center Hospital East
address:
name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan
type:PostalAddress
name:Nihon University School of Medicine
address:
name:Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan
type:PostalAddress
name:Yokohama City University Medical Center
address:
name:Gastroenterological Center, Yokohama City University Medical Center, Kanagawa, Japan
type:PostalAddress
name:Musashino Red Cross Hospital
address:
name:Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan
type:PostalAddress
name:Kyorin University
address:
name:Department of Internal Medicine, Medical Oncology, School of Medicine, Kyorin University, Tokyo, Japan
type:PostalAddress
name:National Cancer Center Hospital
address:
name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan
type:PostalAddress
name:Shinshu University School of Medicine
address:
name:Department of Radiology, Shinshu University School of Medicine, Nagano, Japan
type:PostalAddress
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd.
address:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
type:PostalAddress
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd.
address:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
type:PostalAddress
name:Graduate School of Medicine, University of Tokyo
address:
name:Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Masatoshi Kudo
affiliation:
name:Kinki University School of Medicine
address:
name:Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan
type:PostalAddress
type:Organization
email:[email protected]
name:Masafumi Ikeda
affiliation:
name:National Cancer Center Hospital East
address:
name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan
type:PostalAddress
type:Organization
name:Tadatoshi Takayama
affiliation:
name:Nihon University School of Medicine
address:
name:Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan
type:PostalAddress
type:Organization
name:Kazushi Numata
affiliation:
name:Yokohama City University Medical Center
address:
name:Gastroenterological Center, Yokohama City University Medical Center, Kanagawa, Japan
type:PostalAddress
type:Organization
name:Namiki Izumi
affiliation:
name:Musashino Red Cross Hospital
address:
name:Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan
type:PostalAddress
type:Organization
name:Junji Furuse
affiliation:
name:Kyorin University
address:
name:Department of Internal Medicine, Medical Oncology, School of Medicine, Kyorin University, Tokyo, Japan
type:PostalAddress
type:Organization
name:Takuji Okusaka
affiliation:
name:National Cancer Center Hospital
address:
name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan
type:PostalAddress
type:Organization
name:Masumi Kadoya
affiliation:
name:Shinshu University School of Medicine
address:
name:Department of Radiology, Shinshu University School of Medicine, Nagano, Japan
type:PostalAddress
type:Organization
name:Satoshi Yamashita
affiliation:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd.
address:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
type:PostalAddress
type:Organization
name:Yuichiro Ito
affiliation:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd.
address:
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
type:PostalAddress
type:Organization
name:Norihiro Kokudo
affiliation:
name:Graduate School of Medicine, University of Tokyo
address:
name:Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
type:PostalAddress
type:Organization
PostalAddress:
name:Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan
name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan
name:Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan
name:Gastroenterological Center, Yokohama City University Medical Center, Kanagawa, Japan
name:Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan
name:Department of Internal Medicine, Medical Oncology, School of Medicine, Kyorin University, Tokyo, Japan
name:Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan
name:Department of Radiology, Shinshu University School of Medicine, Nagano, Japan
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
name:Medical Affairs Oncology and Hematology, Bayer Yakuhin, Ltd., Osaka, Japan
name:Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
External Links {🔗}(138)
- https://www.springernature.com/gp/authors income
- Check the income stats for https://link.springernature.com/home/
- What's the total monthly financial gain of https://order.springer.com/public/cart?
- What's https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research's gross income?
- How much does https://www.editorialmanager.com/joga earn?
- What's the profit of https://beta.springernature.com/pre-submission?journalId=535?
- What is the earnings of https://doi.org/10.1053%2Fj.gastro.2011.12.061?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22537432 gross monthly?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338949?
- How much does http://scholar.google.com/scholar_lookup?&title=Epidemiology%20of%20viral%20hepatitis%20and%20hepatocellular%20carcinoma&journal=Gastroenterology&doi=10.1053%2Fj.gastro.2011.12.061&volume=142&pages=1264-1273&publication_year=2012&author=El-Serag%2CHB pull in monthly?
- How much does https://doi.org/10.3322%2Fcaac.20107 rake in every month?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21296855?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Global%20cancer%20statistics&journal=CA%20Cancer%20J%20Clin&doi=10.3322%2Fcaac.20107&volume=61&pages=69-90&publication_year=2011&author=Jemal%2CA&author=Bray%2CF&author=Center%2CMM?
- How much does https://doi.org/10.1016%2Fj.cgh.2005.12.007 pull in monthly?
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16527702
- See how much http://scholar.google.com/scholar_lookup?&title=The%20association%20between%20diabetes%20and%20hepatocellular%20carcinoma%3A%20a%20systematic%20review%20of%20epidemiologic%20evidence&journal=Clin%20Gastroenterol%20Hepatol&doi=10.1016%2Fj.cgh.2005.12.007&volume=4&pages=369-380&publication_year=2006&author=El-Serag%2CHB&author=Hampel%2CH&author=Javadi%2CF makes per month
- Earnings of https://doi.org/10.7314%2FAPJCP.2012.13.3.743
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22631642 generate?
- See how much http://scholar.google.com/scholar_lookup?&title=Risk%20factors%20of%20hepatocellular%20carcinoma%E2%80%93current%20status%20and%20perspectives&journal=Asian%20Pac%20J%20Cancer%20Prev&doi=10.7314%2FAPJCP.2012.13.3.743&volume=13&pages=743-752&publication_year=2012&author=Gao%2CJ&author=Xie%2CL&author=Yang%2CWS makes per month
- Financial intake of https://doi.org/10.1016%2Fj.bpg.2006.07.002
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17223503's financial summary
- How much does http://scholar.google.com/scholar_lookup?&title=Hepatocellular%20carcinoma%20development%20in%20cirrhosis&journal=Best%20Pract%20Res%20Clin%20Gastroenterol&doi=10.1016%2Fj.bpg.2006.07.002&volume=21&pages=161-173&publication_year=2007&author=Okuda%2CH rake in every month?
- What's https://doi.org/10.1200%2FJCO.2005.03.196's gross income?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15860847 bring in each month?
- http://scholar.google.com/scholar_lookup?&title=Hepatocellular%20carcinoma%3A%20the%20need%20for%20progress&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2005.03.196&volume=23&pages=2892-2899&publication_year=2005&author=Thomas%2CMB&author=Zhu%2CAX's total income per month
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15042359?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Randomized%20controlled%20trial%20of%20screening%20for%20hepatocellular%20carcinoma&journal=J%20Cancer%20Res%20Clin%20Oncol&volume=130&pages=417-422&publication_year=2004&author=Zhang%2CBH&author=Yang%2CBH&author=Tang%2CZY?
- What's the financial outcome of https://doi.org/10.1016%2FS0140-6736%2803%2914964-1?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14667750?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Hepatocellular%20carcinoma&journal=Lancet&doi=10.1016%2FS0140-6736%2803%2914964-1&volume=362&pages=1907-1917&publication_year=2003&author=Llovet%2CJM&author=Burroughs%2CA&author=Bruix%2CJ
- How much does https://doi.org/10.1111%2Fj.1365-2036.2006.02932.x make?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16696801 income
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Systematic%20review%3A%20evidence-based%20management%20of%20hepatocellular%20carcinoma-an%20updated%20analysis%20of%20randomized%20controlled%20trials&journal=Aliment%20Pharmacol%20Ther&doi=10.1111%2Fj.1365-2036.2006.02932.x&volume=23&pages=1535-1547&publication_year=2006&author=Lopez%2CPM&author=Villanueva%2CA&author=Llovet%2CJM?
- What are the earnings of https://doi.org/10.1038%2Fnrc1934?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16929323 generate?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Hepatocellular%20carcinoma%20pathogenesis%3A%20from%20genes%20to%20environment&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc1934&volume=6&pages=674-687&publication_year=2006&author=Farazi%2CPA&author=DePinho%2CRA?
- What is the monthly revenue of https://doi.org/10.1097%2FMOG.0b013e32832962a1?
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19387255?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Pathogenesis%20of%20hepatocellular%20carcinoma%20and%20molecular%20therapies&journal=Curr%20Opin%20Gastroenterol&doi=10.1097%2FMOG.0b013e32832962a1&volume=25&pages=186-194&publication_year=2009&author=Minguez%2CB&author=Tovar%2CV&author=Chiang%2CD
- https://doi.org/10.1158%2F0008-5472.CAN-04-1443's total income per month
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15466206 make?
- http://scholar.google.com/scholar_lookup?&title=BAY%2043-9006%20exhibits%20broad%20spectrum%20oral%20antitumor%20activity%20and%20targets%20the%20RAF%2FMEK%2FERK%20pathway%20and%20receptor%20tyrosine%20kinases%20involved%20in%20tumor%20progression%20and%20angiogenesis&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-04-1443&volume=64&pages=7099-7109&publication_year=2004&author=Wilhelm%2CSM&author=Carter%2CC&author=Tang%2CL's total income per month
- Get to know what's the income of https://doi.org/10.1002%2Fhep.24199
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21374666 is on a monthly basis
- Learn how profitable http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084991 is on a monthly basis
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Management%20of%20hepatocellular%20carcinoma%3A%20an%20update&journal=Hepatology&doi=10.1002%2Fhep.24199&volume=53&pages=1020-1022&publication_year=2011&author=Bruix%2CJ&author=Sherman%2CM
- What's https://doi.org/10.1016%2FS1470-2045%2808%2970285-7's gross income?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19095497
- Profit of http://scholar.google.com/scholar_lookup?&title=Efficacy%20and%20safety%20of%20sorafenib%20in%20patients%20in%20the%20Asia-Pacific%20region%20with%20advanced%20hepatocellular%20carcinoma%3A%20a%20phase%20III%20randomised%2C%20double-blind%2C%20placebo-controlled%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2808%2970285-7&volume=10&pages=25-34&publication_year=2009&author=Cheng%2CAL&author=Kang%2CYK&author=Chen%2CZ
- How much income is https://doi.org/10.1056%2FNEJMoa0708857 earning monthly?
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18650514's earnings
- How much does http://scholar.google.com/scholar_lookup?&title=Sorafenib%20in%20advanced%20hepatocellular%20carcinoma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa0708857&volume=359&pages=378-390&publication_year=2008&author=Llovet%2CJM&author=Ricci%2CS&author=Mazzaferro%2CV pull in monthly?
- How much money does https://doi.org/10.1111%2Fj.1742-1241.2010.02414.x generate?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20642705
- How much profit is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905618 making per month?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Design%20and%20rationale%20for%20the%20non-interventional%20global%20investigation%20of%20therapeutic%20decisions%20in%20hepatocellular%20carcinoma%20and%20of%20its%20treatment%20with%20sorafenib%20%28GIDEON%29%20study&journal=Int%20J%20Clin%20Pract&doi=10.1111%2Fj.1742-1241.2010.02414.x&volume=64&pages=1034-1041&publication_year=2010&author=Lencioni%2CR&author=Marrero%2CJ&author=Venook%2CA?
- How profitable is https://doi.org/10.1111%2Fijcp.12352?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24283303 each month?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=GIDEON%20%28global%20investigation%20of%20therapeutic%20decisions%20in%20hepatocellular%20carcinoma%20and%20of%20its%20treatment%20with%20sorafenib%29%3A%20second%20interim%20analysis&journal=Int%20J%20Clin%20Pract&doi=10.1111%2Fijcp.12352&volume=68&pages=609-617&publication_year=2014&author=Lencioni%2CR&author=Kudo%2CM&author=Ye%2CSL
- How much cash flow does https://doi.org/10.1111%2Fj.1742-1241.2012.02940.x have monthly?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22698419 bring in?
- http://scholar.google.com/scholar_lookup?&title=First%20interim%20analysis%20of%20the%20GIDEON%20%28global%20investigation%20of%20therapeutic%20decisions%20in%20hepatocellular%20carcinoma%20and%20of%20its%20treatment%20with%20sorafenib%29%20non-interventional%20study&journal=Int%20J%20Clin%20Pract&doi=10.1111%2Fj.1742-1241.2012.02940.x&volume=66&pages=675-683&publication_year=2012&author=Lencioni%2CR&author=Kudo%2CM&author=Ye%2CSL's total income per month
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Nexavar%C2%AE%20Tablets%20200%C2%A0Mg%20%28nonproprietary%20nane%3A%20sorafenib%20tosylate%20tablets%29%20specific%20drug%20use%20investigation%20interim%20report%20%28unresectable%20hepatocellular%20carcinoma%29&publication_year=2012
- What's the financial gain of https://doi.org/10.2214%2Fajr.175.3.1750699?
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10954453 earning monthly?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Comparison%20of%20CT%20findings%20with%20resected%20specimens%20after%20chemoembolization%20with%20iodized%20oil%20for%20hepatocellular%20carcinoma&journal=AJR%20Am%20J%20Roentgenol&doi=10.2214%2Fajr.175.3.1750699&volume=175&pages=699-704&publication_year=2000&author=Takayasu%2CK&author=Arii%2CS&author=Matsuo%2CN?
- Earnings of https://doi.org/10.1111%2Fj.1872-034X.2010.00674.x
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20633194
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Response%20evaluation%20criteria%20in%20cancer%20of%20the%20liver%20%28RECICL%29%20proposed%20by%20the%20Liver%20Cancer%20Study%20Group%20of%20Japan%20%282009%20revised%20version%29&journal=Hepatol%20Res&doi=10.1111%2Fj.1872-034X.2010.00674.x&volume=40&pages=686-692&publication_year=2010&author=Kudo%2CM&author=Kubo%2CS&author=Takayasu%2CK
- How much cash flow does https://doi.org/10.1055%2Fs-0030-1247132 have monthly?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20175033
- How much money does http://scholar.google.com/scholar_lookup?&title=Modified%20RECIST%20%28mRECIST%29%20assessment%20for%20hepatocellular%20carcinoma&journal=Semin%20Liver%20Dis&doi=10.1055%2Fs-0030-1247132&volume=30&pages=52-60&publication_year=2010&author=Lencioni%2CR&author=Llovet%2CJM generate?
- Revenue of https://doi.org/10.1016%2FS0168-8278%2815%2930585-7
- http://scholar.google.com/scholar_lookup?&title=GIDEON%3A%20a%20retrospective%20analysis%20of%20prognostic%20factors%5BAbstract%5D&journal=J%20Hepatol&doi=10.1016%2FS0168-8278%2815%2930585-7&volume=62&issue=suppl%202&publication_year=2015&author=Bronowicki%2CJP&author=Kudo%2CM&author=Lencioni%2CR's total income per month
- https://doi.org/10.1016%2FS0168-8278%2814%2960112-4's financial summary
- What's the profit of http://scholar.google.com/scholar_lookup?&title=An%20international%20collaborative%20study%20assessing%20the%20role%20of%20aetiology%20and%20stage%20in%20survival%20in%20HCC-implications%20for%20screening&journal=J%20Hepatol&doi=10.1016%2FS0168-8278%2814%2960112-4&volume=60&issue=suppl&pages=S45-S46&publication_year=2014&author=Johnson%2CP&author=Berhane%2CS&author=Satomura%2CS?
- See how much https://doi.org/10.1159%2F000342749 makes per month
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24159578 gross monthly?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3760465 pull in?
- What's http://scholar.google.com/scholar_lookup?&title=Japan%E2%80%99s%20successful%20model%20of%20nationwide%20hepatocellular%20carcinoma%20surveillance%20highlighting%20the%20urgent%20need%20for%20global%20surveillance&journal=Liver%20Cancer&doi=10.1159%2F000342749&volume=1&pages=141-143&publication_year=2012&author=Kudo%2CM's gross income?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25213161?
- http://scholar.google.com/scholar_lookup?&title=Randomized%20phase%20III%20trial%20of%20regorafenib%20in%20metastatic%20colorectal%20cancer%3A%20analysis%20of%20the%20CORRECT%20Japanese%20and%20non-Japanese%20subpopulations&journal=Invest%20New%20Drugs&doi=10.1007%2Fs10637-014-0154-x&volume=33&pages=740-750&publication_year=2015&author=Yoshino%2CT&author=Komatsu%2CY&author=Yamada%2CY's financial summary
- What are the total earnings of https://doi.org/10.1159%2F000327577?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21829027's financial summary
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Management%20of%20hepatocellular%20carcinoma%20in%20Japan%3A%20consensus-based%20clinical%20practice%20guidelines%20proposed%20by%20the%20Japan%20Society%20of%20Hepatology%20%28JSH%29%202010%20updated%20version&journal=Dig%20Dis&doi=10.1159%2F000327577&volume=29&pages=339-364&publication_year=2011&author=Kudo%2CM&author=Izumi%2CN&author=Kokudo%2CN?
- https://doi.org/10.1159%2F000368142's financial summary
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25427730's total income per month
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Transarterial%20chemoembolization%20failure%2Frefractoriness%3A%20JSH-LCSGJ%20criteria%202014%20update&journal=Oncology&doi=10.1159%2F000368142&volume=87&issue=Suppl%201&pages=22-31&publication_year=2014&author=Kudo%2CM&author=Matsui%2CO&author=Izumi%2CN
- How much money does https://doi.org/10.1159%2F000365993 make?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25227534 produce monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Efficacy%20of%20sorafenib%20in%20intermediate-stage%20hepatocellular%20carcinoma%20patients%20refractory%20to%20transarterial%20chemoembolization&journal=Oncology&doi=10.1159%2F000365993&volume=87&pages=330-341&publication_year=2014&author=Ogasawara%2CS&author=Chiba%2CT&author=Ooka%2CY rake in every month?
- How much cash flow does https://doi.org/10.1159%2F000367743 have monthly?
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26734579 makes per month
- How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698649 make?
- http://scholar.google.com/scholar_lookup?&title=Effectiveness%20of%20sorafenib%20in%20patients%20with%20transcatheter%20arterial%20chemoembolization%20%28TACE%29%20refractory%20and%20intermediate-stage%20hepatocellular%20carcinoma&journal=Liver%20Cancer&doi=10.1159%2F000367743&volume=4&pages=253-262&publication_year=2015&author=Arizumi%2CT&author=Ueshima%2CK&author=Minami%2CT's financial summary
- What's the income generated by https://citation-needed.springer.com/v2/references/10.1007/s00535-016-1204-2?format=refman&flavour=references each month?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Masatoshi%20Kudo's revenue stream
- Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Masatoshi%20Kudo%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Masafumi%20Ikeda make?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Masafumi%20Ikeda%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in monthly?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tadatoshi%20Takayama produce monthly?
- Learn how profitable https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tadatoshi%20Takayama%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en is on a monthly basis
- What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kazushi%20Numata?
- Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kazushi%20Numata%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What are the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Namiki%20Izumi?
- How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Namiki%20Izumi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
- What's the revenue for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Junji%20Furuse?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Junji%20Furuse%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Takuji%20Okusaka make?
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Takuji%20Okusaka%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Masumi%20Kadoya bring in?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Masumi%20Kadoya%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in monthly?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Satoshi%20Yamashita make?
- What's the income generated by https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Satoshi%20Yamashita%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en each month?
- Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yuichiro%20Ito's earnings
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yuichiro%20Ito%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en income
- What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Norihiro%20Kokudo?
- How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Norihiro%20Kokudo%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
- How much revenue does https://static-content.springer.com/esm/art%3A10.1007%2Fs00535-016-1204-2/MediaObjects/535_2016_1204_MOESM1_ESM.docx generate?
- What's the financial gain of http://creativecommons.org/licenses/by/4.0/?
- Earnings of https://s100.copyright.com/AppDispatchServlet?title=Safety%20and%20efficacy%20of%20sorafenib%20in%20Japanese%20patients%20with%20hepatocellular%20carcinoma%20in%20clinical%20practice%3A%20a%20subgroup%20analysis%20of%20GIDEON&author=Masatoshi%20Kudo%20et%20al&contentID=10.1007%2Fs00535-016-1204-2©right=The%20Author%28s%29&publication=0944-1174&publicationDate=2016-04-22&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY
- https://crossmark.crossref.org/dialog/?doi=10.1007/s00535-016-1204-2's revenue stream
- How much revenue does https://citation-needed.springer.com/v2/references/10.1007/s00535-016-1204-2?format=refman&flavour=citation generate?
- How much profit is https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral making per month?
- Financial intake of https://www.springernature.com/gp/products
- What's the revenue for https://www.springernature.com/gp/librarians?
- Profit of https://www.springernature.com/gp/societies
- https://www.springernature.com/gp/partners's revenue stream
- How much profit does https://www.springer.com/ make?
- Earnings of https://www.nature.com/
- https://www.biomedcentral.com/'s total income per month
- How much money does https://www.palgrave.com/ generate?
- How much income does https://www.apress.com/ have?
- What's the revenue for https://www.springernature.com/gp/legal/ccpa?
- How much does https://www.springernature.com/gp/info/accessibility rake in every month?
- What's the total monthly financial gain of https://support.springernature.com/en/support/home?
- How profitable is https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
- How profitable is https://www.springernature.com/?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref